Therapeutic Goods Act 1989 Approval under section 42DF for use of restricted representations by Novo Nordisk Pharmaceuticals Pty Ltd

I, Rowena Love, as a delegate of the Secretary to the Department of Health and Aged Care, have approved under section 42DF of the Therapeutic Goods Act 1989, the restricted representations described in paragraph (A), for use in advertising the product identified in paragraph (B) to consumers.

       (A) 1. For people living with diabetes who require the administration of insulin
              2. For people who require the administration of insulin as a part of their diabetes management together,  (the Representations).

To avoid doubt, a reference in an advertisement that is made in accordance with this approval notice, relating to therapeutic goods containing a substance included in Schedule 3, 4 or 8 to the current Poisons Standard but not in Appendix H of the current Poisons Standard, is by virtue of this approval notice also authorised by the Australian Government Department of Health and Aged Care for the purposes of subsections 42DL(10) and 42DLB(7) of the Act.

Dated this 17th day of August 2023

Signed electronically

Rowena Love
Delegate of the Secretary to the Department of Health and Aged Care
Advertising and Compliance Education and Policy Section
Regulatory Compliance Branch